ver since scientists first switched adult human cells into an embryonic-like state from which they can develop into any tissue type, recipes for making these induced pluripotent stem (iPS) cells have multiplied.
However, many rely on the introduction of foreign genes by viruses, which makes the altered cells unsuitable for use in patients. Now researchers have replaced all but one of the genes with a cocktail of chemicals, taking scientists a step closer to creating patient-specific iPS cells that could be used in the clinic.
The advance, by chemist Sheng Ding at the Scripps Research Institute in San Diego, California, and his colleagues (Zhu, S. et al. Cell Stem Cell 7, 651-655; 2010 
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Replacing genes with drugs could allow safe reprogramming.
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